CenterPoint Energy CNP benefits from rising electricity consumption, driven by the rapid electrification of transportation ...

Ascendis Pharma A/S (Nasdaq: ASND) today announced that pivotal Week 52 results from its randomized double-blind, ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

In recent trading, shares of CenterPoint Energy, Inc (Symbol: CNP) have crossed above the average analyst 12-month target price of $32.50, changing hands for $32.54/share. When a stock reaches the ...

Ascendis Pharma (ASND) announced that pivotal Week 52 results from its randomized double-blind, placebo-controlled ApproaCH Trial of ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The FDA has granted Cour Pharmaceuticals orphan drug ...

CenterPoint Energy (CNP) shares have climbed steadily this year, gaining 24% year-to-date and 36% over the past year. Recent trading activity has reflected a measured optimism as investors weigh the ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...